FDBusiness.com

Biotech Company Nuritas Discovers New MRSA Killing Peptide

 Breaking News
  • Irish Supermarkets Benefit From the Christmas Spirit The latest grocery market share figures from Kantar Worldpanel in Ireland, for the 12 weeks ending 31 December 2017, reveal that shoppers spent an extra €90 million on groceries over the festive period. David Berry, director at Kantar Worldpanel, comments: “Over the Christmas period the average household spent a record €1,532 on groceries – an increase of [...]...
  • Britvic Continues to Put Health at the Heart of its New Sustainable Business Programme Britvic has launched ‘A Healthier Everyday’, its new sustainable business programme which builds on its commitment to: help consumers make healthier choices; support the well-being of communities; and minimise its impact on the planet. The creation of ‘A Healthier Everyday’ follows a review by the company into how it can ensure that its sustainability programme is [...]...
  • Bayn Europe Sets Up Chinese Subsidiary For Sugar Reduction Bayn Europe AB has signed a joint venture agreement with real estate development company HuaHe International Asset Management to introduce sugar reduction to the China market. Both partners agreed on a co-operation model and mutual commitments for the set up of joint venture. Bayn will hold 65% of equity and HuaHe will hold 35%. Further to [...]...
  • Ishida X-ray Flexibility Ensures Premium Product Quality Ishida X-ray inspection technology is helping to maintain the premium quality reputation of one of Russia’s most popular traditional snack brands. The ‘ROSTRAGROEXPORT’ company was founded by Mr Boris Aleksandrov in 1995, who spotted a niche in the Russian food market for a good quality traditional curd snack.  Its ‘B.Y. Aleksandrov’ brand, named after the company’s [...]...
  • ‘Latte Levy’ – Coffee Drinkers Want to Go Green, But Price is a Barrier As the UK Government aims to eliminate avoidable waste with the announcement of its 25-Year Environmental Plan, Mintel research reveals that Britain’s coffee shop drinkers are happy to do their bit for the environment, but not at any cost. 40% of out of home hot drinks consumers wouldn’t mind paying extra for drinks served in 100% [...]...

Biotech Company Nuritas Discovers New MRSA Killing Peptide

December 06
15:42 2014

Nuritas PhotoIrish bioinformatics company, Nuritas, today announced that it has discovered an MRSA killing peptide. The peptide, which is derived from a food by-product, is anticipated to provide a natural, healthy innovation in the fight against antibiotic resistant infections in both humans and animals.

Nuritas’ ground-breaking biotechnology is capable of quickly and cost-effectively harvesting ingredients which then may be developed and supplied to humans and animal producers for many different applications from topical applications to effective cleaning biocides.

Dr. Nora Khaldi, CEO of Nuritas, states “Our aim is to make ingredients that are more accessible, natural and meeting serious societal health needs.”

Unlike existing MRSA killing products, Nuritas has found a way to rapidly and effectively extract and activate safe and healthy antimicrobial molecules in food that are often overlooked. This is a world first in that most molecules are usually derived from non-sustainable sources that have unknown side effects on human health and cost millions and years to develop.

Dr. Marta Martins, Biotechnology Research Fellow at University College Dublin said that “The increase of antibiotic resistance in bacteria of clinical relevance is a major issue for Public Health and there is the immediate need for alternative solutions”. Nuritas’ announcement today of the discovery of an effective and natural peptide to combat MRSA comes at a crucial point in the MRSA battle it seems.

Staphylococcus aureus is a bacterium commonly found in the nose and/or skin of healthy persons and animals. Strains of this bacterium that are resistant to beta-lactam antibiotics are called Methicillin-Resistant Staphylococcus aureus (MRSA). If this bacterium penetrates the skin and enters the blood stream it can cause life-threatening infections due to its resistance to many of the currently used antibiotics.

The inappropriate use of antibiotics in human treatments and animal production is contributing to antibiotic resistance, allowing bacterium such as Staphylococcus aureus to continue to evolve. Developing treatments to keep up with the evolution of the bacterium are costly and time-consuming. Severe side effects are also associated with some of the second or last-line antibiotic treatments. Nuritas’ ingredients are cost-effectively and quickly mined from food sources eliminating the possible severe side effects associated with current therapies and uses.

Overall, Nuritas’ discovery has the potential to provide innovative treatment of the costly and dangerous MRSA causing-infections by providing affordable, healthy, sustainable anti-microbials to ensure the healthy, long life of humans and animals.

 

About Nuritas

downloadNuritas is a biotechnology company that radically changes the way we discover natural peptides that target key receptors to actively promote and manage health. The company uses artificial intelligence to data mine food, allowing the discovery of life-changing ingredients that can be added to personal care products, supplements, food or biocides. Nuritas is committed to applying its scientific expertise to translate nature into healthy, sustainable and cost-effective living for all.

About Author

colin

colin

Related Articles



Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • January 16, 2018Sival Plant Production Trade Show
  • January 17, 2018Anfas Food Product
  • January 17, 2018Dutch Organic Trade Fair
  • January 19, 2018International Green Week
AEC v1.0.4

find food jobs

The Magazine

F&D Business Preferred Suppliers

New Subscriber





Subscribe Here



Advertisements